COVID-19 vaccination in rheumatology patients: What experts say

Patients on rituximab might need to postpone or delay therapy, they suggest

UK experts have proposed evidence-based management strategies for rheumatology patients on immunosuppressive therapy, including delaying or postponing rituximab, as appropriate.

Senior woman having vaccination

In a commentary in Rheumatology, Dr Paul Emery of the University of Leeds and colleagues outline data on the effect of antirheumatic therapy on vaccine responses in patients with inflammatory arthritis.

One aim of their article was “to formulate a possible pragmatic strategy for the management of therapies